← Back to Search

Treatment for Lung Cancer

N/A
Recruiting
Led By Lillian Siu, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

The Marathon of Hope Cancer Centres Network (MOHCCN) is a national network of cancer centres that pursue collaborative cancer research in precision medicine (an emerging approach for disease treatment and prevention that considers individual variability in DNA, environment and lifestyle) to accelerate the discovery of innovations and improve the health outcomes for cancer patients

Eligible Conditions
  • Lung Cancer
  • Prostate Cancer
  • Pancreatic Cancer
  • Head and Neck Cancers
  • Colorectal Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Kidney Cancer
  • Lymphoma
  • Melanoma
  • Leukemia
  • Solid Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients included in a pan-Canadian cohort with comprehensive clinical and genomic data
Secondary outcome measures
Pharmaceutical Preparations
Development and collection of patient-reported outcomes to enhance patient-centeredness in precision cancer medicine
Development of standard practices to create a unique shareable dataset of molecular, imaging, clinical and health outcome information on Canadian cancer cases

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,514 Previous Clinical Trials
499,705 Total Patients Enrolled
Princess Margaret Hospital, CanadaOTHER
119 Previous Clinical Trials
38,604 Total Patients Enrolled
Ontario Institute for Cancer ResearchOTHER
23 Previous Clinical Trials
8,673 Total Patients Enrolled
~235 spots leftby Oct 2026